A prospective study evaluating the impact of cartridge-based nucleic acid amplification test (CBNAAT) on the management of tuberculosis in a low-resource high-burden Indian rural setting
Background: The cartridge-based nucleic acid amplification test (CBNAAT) Xpert MTB/RIF is more sensitive than smear microscopy for the diagnosis of tuberculosis (TB). It is also more expensive, costing 1450 INR as compared to 10 INR per smear. Objectives: We conducted a prospective study to evaluate...
Main Authors: | Jonathan Youngs, Sushil Patil, Yogesh Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2018;volume=7;issue=5;spage=982;epage=992;aulast=Youngs |
Similar Items
-
Application of CBNAAT (Xpert MTB/RIF assay) in new smear negative pulmonary tuberculosis patients
by: Vishal Chopra, et al.
Published: (2020-02-01) -
Detection of Rifampicin Resistance in HIV Seropositive Individuals with Suspected Pulmonary Tuberculosis by Using CBNAAT
by: Shilpa, et al.
Published: (2017-03-01) -
Cartridge Based Nucleic Acid Amplification Test: The Sherlock of Tuberculosis
by: Jureka Mankotia, et al.
Published: (2019-03-01) -
Cerebrospinal fluid Gene XPERT (CBNAAT) in children with tuberculous meningitis
by: Annapurna Rai, et al.
Published: (2021-08-01) -
Impact of Lockdown on Tuberculosis Management during SARS-Cov-2 Pandemic : Urban & Rural Scenario of Surat
by: Parul Vadgama, et al.
Published: (2021-06-01)